Welcome to our dedicated page for Albemarle SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Albemarle Corporation (NYSE: ALB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Virginia-incorporated public company with common stock listed on the NYSE, Albemarle regularly submits reports that cover financial results, material agreements, governance updates and other significant events.
Among the key documents are Form 8-K current reports, where Albemarle discloses items such as quarterly earnings releases, material definitive agreements, goodwill impairment conclusions, director and officer changes, and organizational structure updates. For example, recent 8-K filings have described the company’s third quarter results, the stock purchase agreement related to the sale of a controlling stake in Ketjen’s refining catalyst solutions business, the planned sale of its interest in the Eurecat joint venture, and changes in senior leadership roles.
Investors can also use this page to locate references to Albemarle’s use of proceeds from portfolio transactions, its assessment of impairment charges, and its classification of certain businesses as held for sale. These filings help explain how Albemarle manages its lithium, bromine and catalyst-related operations within its broader financial and strategic framework.
Stock Titan enhances access to Albemarle’s filings by pairing real-time updates from EDGAR with AI-powered summaries that highlight the main points of lengthy documents. Users can quickly understand the implications of new 8-Ks, as well as the content of other core filings such as annual and quarterly reports, and can review disclosures related to executive arrangements and board changes without reading every line of the original text.
ALBEMARLE CORP Chairman & CEO J Kent Masters reported equity compensation activity involving company common stock. He acquired 9,032 shares at $184.93 per share as a grant or award, bringing his direct holdings to 127,885 shares immediately after this acquisition and 123,961 shares after related tax withholding.
The shares came from Performance Stock Units granted on 02/24/2023, with 50% tied to ROIC performance and 50% to relative total shareholder return (rTSR). No shares were earned under the ROIC component, while all shares under the rTSR component vested on 02/26/2026.
To cover tax liabilities from this vesting, 3,924 shares were disposed of through share withholding at $184.93 per share, which is a tax-withholding disposition rather than an open-market sale.
Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation director Michelle T. Collins received a grant of 325 shares of common stock as part of non-employee director stock compensation. The award was granted under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors and carries a grant price of $0.00 per share.
These shares are scheduled to vest on July 1, 2026. After this grant, Collins directly holds 325 shares of Albemarle common stock, reflecting her current equity-based compensation as a newly appointed director within the compensation year.
Albemarle Corp director Michelle T. Collins filed an initial Form 3 to report her status as an insider of the company. This filing establishes her as a reporting person for future disclosures of Albemarle stock ownership or transactions but does not list any current transactions or share amounts.
ALBEMARLE CORP director Mark R. Widmar filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a director and provides a baseline disclosure of any equity holdings associated with his role. The data provided shows no reported transactions at this time.
Albemarle Corporation reported that General Counsel & Secretary Ander C. Krupa had 188 shares of common stock withheld on February 24, 2026 at $186.83 per share to cover taxes on vested restricted stock units. After this tax-withholding disposition, Krupa directly owns 11,295 shares.
Albemarle Corp Chief People Officer Autumn M. Gagarinas reported automatic share disposals tied to tax withholding. On 2/24/2026, a total of 566 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting restricted stock units granted on 2/24/2023. Following these tax-withholding dispositions, she directly held 3,488 shares of Albemarle common stock.
Albemarle Corporation senior vice president Cynthia Renee Lima reported automatic share disposals to cover taxes on restricted stock unit vesting. On the common stock, 196 shares and 144 shares were withheld on February 24, 2026 at a price of $186.83 per share as tax-withholding dispositions.
After these entries, she directly owned 12,559 common shares. A footnote explains that this filing also updates her reported holdings to include 4,806 unvested RSUs from awards granted on February 24, 2023, aligning treatment of time-based RSUs with other Albemarle reporting persons.
Albemarle Corp executive Melissa H. Anderson reported a tax-related share disposition. On 24 February 2026, 565 shares of common stock were withheld at $186.83 per share to cover tax liabilities tied to vesting restricted stock units granted on 24 February 2023. After this withholding, she directly held 8,874 shares. She also indirectly held 179.1617 shares through the Albemarle Corporation Retirement Savings Plan as of this Form 4.
Albemarle Corporation VP and CAO Donald J. LaBauve Jr. reported a tax-withholding disposition of 164 shares of Common Stock at $186.83 per share on Restricted Stock Units that vested from a grant dated 2/24/2023. After this, he directly holds 8,647 shares, and indirectly holds 12,755 shares through the Albemarle Savings Plan.
ALBEMARLE CORP Chief Commercial Officer Eric Norris reported a tax-related share disposition. On 2/24/2026, 887 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting Restricted Stock Units granted on 2/24/2023. After this transaction, Norris directly holds 47,932 shares of Albemarle common stock.